BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs
BIOPHARM, Výzkumný ústav biofarmacie a veterinárních léčiv

Czech Republic

1 August 2019 - 31 July 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs published between 1 August 2019 - 31 July 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.36

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0.36
1 0.36
Precise CRISPR/Cas9 editing of the NHE1 gene renders chickens resistant to the J subgroup of avian leukosis virus.
2020-01-21
0.36

Top articles by Altmetric score in current window

Precise CRISPR/Cas9 editing of the NHE1 gene renders chickens resistant to the J subgroup of avian leukosis virus.

Proceedings of the National Academy of Sciences of the United States of America

2020-01-21

1 August 2019 - 31 July 2020

International vs. domestic collaboration by Share

  • 100% Domestic
  • 0% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (1 total)

  • BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, Czech Republic
  • Domestic institution
  1. Czech Academy of Sciences (CAS), Czech Republic (1)
    0.36
    0.64

Top 10 international collaborators by Share (0 total)

  • BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, Czech Republic
  • Foreign institution

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Return to institution outputs